Davion Healthcare Plc
Davion Healthcare Plc
Your view on DAVI
Overview
What the company does, where it operates, and who runs it.
About Davion Healthcare Plc
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Glenn Williams
- Headquarters
- West Cork Business & Technology Park, Cork, IE
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Glenn Williams
- Headquarters
- West Cork Business & Technology Park, Cork, IE
Davion Healthcare Plc is an Irish public limited company that develops and commercializes non-invasive home tests for the early detection of health anomalies, including cancers.
Its products use thermography: a liquid crystal film placed on the skin shows temperature differences as color shifts, and AI analysis of smartphone images interprets the result. It has four completed tests, BreastCheck, FootFlow (diabetic circulation), Testic and ThermaDerm, all non-diagnostic Class I devices.
BreastCheck and FootFlow have been FDA-registered, and registered in the EU and UK, since November 2023. The company was incorporated in Cyprus in 2022 and re-domiciled to Ireland in 2024, keeping a wholly owned Cyprus subsidiary.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Davion Healthcare Plc from FRC's valuation model, read against the market price. DAVI last traded at $1.07; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Davion Healthcare Plc. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Davion Healthcare Plc. Davion Healthcare Plc does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Davion Healthcare Plc. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Davion Healthcare Plc. Davion Healthcare Plc has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
More Medical - Devices companies
Market cap
- CTKBCytek Biosciences, Inc.NASDAQ$774M
- CTSOCytosorbents CorporationNASDAQ$18M
- CVCapsoVision, Inc.NASDAQ$366M
- CVRXCVRx, Inc.NASDAQ$17M
- CYBQFCYBERDYNE Inc.OTC$262M
- CYBQYCYBERDYNE Inc.OTC$414M
- CYC.AXCyclopharm LimitedASX
- CYDXCYduct Diagnostics, Inc.OTC$4M
- DCTHDelcath Systems, Inc.NASDAQ$685M
- DGWPFDrägerwerk AG & Co. KGaAOTC$1.4B
- DHAIDIH Holding US, Inc.NASDAQ
- DRORDror Ortho-Design, Inc.OTC$10M
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Davion Healthcare Plc, and how their positions are changing. At a $26.8M market value, institutional positions materially move Davion Healthcare Plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Davion Healthcare Plc executives and directors. Shares of Davion Healthcare Plc have traded between $0.91 and $12.30 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Davion Healthcare Plc. Davion Healthcare Plc is a $26.8M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Davion Healthcare Plc. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Davion Healthcare Plc. Coverage tracks Davion Healthcare Plc within Medical - Devices (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Davion Healthcare Plc.